C5 - complement C5 Gene
Species: Bos taurus
Gene Type: protein coding
Gene ID: 512045
C5 Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_001166616.1 | NP_001160088.1 | complement C5a anaphylatoxin precursor |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
complement C5a anaphylatoxin |
|
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
Bioactive Molecules
(10)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-14541 | Olanzapine | 99.96% | Yes | |
| HY-17627 | Avacopan | Inhibitor | 98.50% | Yes |
| HY-147080 | Avacincaptad pegol sodium | Inhibitor | 94.64% | Unkown |
| HY-P3502 | Zilucoplan | Inhibitor | 99.71% | Unkown |
| HY-B1213 | Trimipramine maleate | 99.88% | Unkown | |
| HY-B2169 | Melperone | 99.84% | Yes | |
| HY-148457 | Avacincaptad pegol | Inhibitor | 92.50% | Unkown |
| HY-14541R | Olanzapine (Standard) | 99.98% | Unkown | |
| HY-B1213A | Trimipramine | / | Unkown | |
| HY-P3502A | Zilucoplan TFA | Inhibitor | / | Unkown |
Bioactive MoleculesInhibitory Antibodies
(5)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P9914 | Eculizumab | Inhibitor | 99.88% | Unkown |
| HY-P99394 | Talquetamab | 96.44% | Unkown | |
| HY-P99365 | Ravulizumab | Inhibitor | 95.57% | Unkown |
| HY-P99965 | Crovalimab | Inhibitor | 99.59% | Unkown |
| HY-P99786 | Pozelimab | Inhibitor | 99.42% | Unkown |
Clinical Phase
Bioactive Molecules
(14)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase
|
|---|---|---|---|---|
| HY-E70206 | CpG Methyltransferase | / | Phase 4 | |
| HY-14541A | Olanzapine hydrochloride | / | Phase 4 | |
| HY-145720 | Cemdisiran | Inhibitor | 98.43% | Phase 3 |
| HY-145720A | Cemdisiran sodium | 96.30% | Phase 3 | |
| HY-101324A | MK-212 monohydrochloride | Agonist | 99.69% | Phase 3 |
| HY-101324 | MK-212 | Agonist | / | Phase 3 |
| HY-103109 | Melperone hydrochloride | / | Phase 3 | |
| HY-P10653 | C5A | Inhibitor | / | Phase 3 |
| HY-106178 | PMX-53 | Antagonist | 99.95% | Phase 2 |
| HY-111200 | Vabicaserin hydrochloride | Agonist | 99.47% | Phase 2 |
| HY-105277 | Amesergide | Antagonist | / | Phase 2 |
| HY-19283 | DU125530 | Antagonist | / | Phase 2 |
| HY-W008820 | Glutaric acid | 98.44% | Phase 1 | |
| HY-123044 | Tedatioxetine | Antagonist | / | Phase 1 |
Bioactive MoleculesInhibitory Antibodies
(11)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase
|
|---|---|---|---|---|
| HY-P99520 | Vilobelimab | Inhibitor | 99.27% | Phase 3 |
| HY-P99638 | Gefurulimab | Inhibitor | 97.88% | Phase 3 |
| HY-P99886 | Pexelizumab | Inhibitor | 99.0% | Phase 3 |
| HY-P99450 | Avdoralimab | Inhibitor | 99.25% | Phase 2 |
| HY-P99322 | Tesidolumab | Inhibitor | 98.80% | Phase 2 |
| HY-P991022 | Ruxoprubart | Inhibitor | 95.541% | Phase 2 |
| HY-P99767 | Olendalizumab | Inhibitor | 97.43% | Phase 2 |
| HY-P990753 | Omoprubart | Inhibitor | 97.769% | Phase 2 |
| HY-P991067 | Vensobafusp alfa | Inhibitor | 97% | Phase 2 |
| HY-P990745 | Izastobart | Ligand | 99% | Phase 1 |
| HY-P991657 | MEDI7814 | Inhibitor | / | Phase 1 |
Pre-clinical Phase
Bioactive Molecules
(502)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-N0390S1 | L-Glutamine-13C5 | 99.93% | Unkown | |
| HY-149652 | IRF5-IN-1 | Inhibitor | 99.91% | Unkown |
| HY-128729 | DNA2 inhibitor C5 | Inhibitor | 98.51% | Unkown |
| HY-138161 | JR14a | Antagonist | 99.77% | Unkown |
| HY-103124 | DOI hydrochloride | Agonist | 99.61% | Unkown |
| HY-110136A | PMX 205 Trifluoroacetate | Antagonist | 99.50% | Unkown |
| HY-D1612 | BODIPY FL C5-Ceramide | 99.65% | Unkown | |
| HY-B0228S1 | Adenosine-13C5 | 99.9% | Unkown | |
| HY-W013636S | 2-Ketoglutaric acid-13C5 | 99.92% | Unkown | |
| HY-NP004 | Cobra Venom Factor | Activator | 99.07% | Unkown |
| HY-110136 | PMX 205 | Antagonist | 99.54% | Unkown |
| HY-N0092S2 | Inosine-13C5 | Agonist | 99.90% | Unkown |
| HY-14608S3 | L-Glutamic acid-13C5,15N | 99.9% | Unkown | |
| HY-N0326S5 | L-Methionine-13C5 | 99.96% | Unkown | |
| HY-14608S5 | L-Glutamic acid-13C5 | 99.81% | Unkown | |
| HY-126523 | N3-C5-NHS ester | ≥98.0% | Unkown | |
| HY-N0717S6 | L-Valine-13C5 | 99.6% | Unkown | |
| HY-Y0252S | L-Proline-13C5 | 99.93% | Unkown | |
| HY-148141 | JPE-1375 | Antagonist | 99.96% | Unkown |
| HY-W004710 | NH2-C5-NH-Boc | 99.59% | Unkown | |
| HY-N0390S6 | L-Glutamine-13C5,15N2 | 98.0% | Unkown | |
| HY-W017018S2 | L-Ornithine-1,2,3,4,5-13C5 hydrochloride | 99.88% | Unkown | |
| HY-130946 | NH2-C5-PEG4-N3-L-Lysine-PEG3-N3 | 99.42% | Unkown | |
| HY-145237 | BM213 | 99.81% | Unkown | |
| HY-125876 | PROTAC Bcl2 degrader-1 | Inhibitor | 99.80% | Unkown |
| HY-B0445S | NAD+-13C5 ammonium | 98.89% | Unkown | |
| HY-130703 | 5-Dehydroepisterol | Inhibitor | 91.96% | Unkown |
| HY-164088 | DBM-C5-VC-PAB-MMAE | Inhibitor | 99.45% | Unkown |
| HY-16992A | W-54011 | 99.57% | Unkown | |
| HY-132248 | C5 Lenalidomide | Inhibitor | 99.62% | Unkown |
| HY-P5506 | C5a Receptor agonist, W5Cha | Agonist | 99.13% | Unkown |
| HY-Y0520S | Itaconic acid-13C5 | 99.22% | Unkown | |
| HY-D1610 | BODIPY FL C5 | 99.59% | Unkown | |
| HY-Y0252S4 | L-Proline-13C5,15N | 99.93% | Unkown | |
| HY-128342 | Complement C5-IN-1 | Inhibitor | 98.76% | Unkown |
| HY-157080 | Dibromomaleimide-C5-COOH | 99.40% | Unkown | |
| HY-P0014S1 | Liraglutide-13C5,15N tetraTFA | Agonist | 97.74% | Unkown |
| HY-B1449S10 | Uridine-13C5 | 99.90% | Unkown | |
| HY-B1511S | Cyclic AMP-13C5 | 97.45% | Unkown | |
| HY-D1613 | BODIPY FL C5-HPC | 99.43% | Unkown | |
| HY-151667 | Biotin-C5-Azide | 98.92% | Unkown | |
| HY-N0717S1 | L-Valine-13C5,15N | 99.64% | Unkown | |
| HY-110060 | NDT 9513727 | Antagonist | 99.35% | Unkown |
| HY-N0326S6 | L-Methionine-13C5,15N | 99.62% | Unkown | |
| HY-W040055S | Neopterin-13C5 | 97.53% | Unkown | |
| HY-15543A | CP-809101 hydrochloride | Agonist | 98.61% | Unkown |
| HY-W008820S1 | Glutaric acid-d4 | 99.46% | Unkown | |
| HY-P10639 | C5aR2 agonist P32 | Agonist | 99.17% | Unkown |
| HY-N0091S2 | Hypoxanthine-13C5 | 99.74% | Unkown | |
| HY-122725B | Lenalidomide-C5-NH2 hydrochloride | 99.28% | Unkown | |
| HY-136237 | Thalidomide-NH-C5-NH2 hydrochloride | Inducer | 99.86% | Unkown |
| HY-148671 | (S,R,S)-AHPC-amido-C7-acid | 98.71% | Unkown | |
| HY-W018772S15 | D-Ribose(mixture of isomers)-13C5 | 99.95% | Unkown | |
| HY-141840 | GLP-1R modulator C5 | Modulator | 99.81% | Unkown |
| HY-W008137 | 5-Bromo-2-fluoropyrimidine | 99.70% | Unkown | |
| HY-117971 | BVT173187 | Inhibitor | 99.97% | Unkown |
| HY-132141 | 5-PA-dUTP | 99.59% | Unkown | |
| HY-138848A | Thalidomide-4-O-C5-NH2 hydrochloride | Inducer | 96.87% | Unkown |
| HY-14879S2 | Avibactam sodium salt-13C5 | Inhibitor | 99.9% | Unkown |
| HY-160241 | Lenalidomide-C5-acid | 96.01% | Unkown | |
| HY-B1654S | Flavin adenine dinucleotide-13C5 ammonium | 90.08% | Unkown | |
| HY-113038AS | α-Hydroxyglutaric acid-13C5 disodium | 99.80% | Unkown | |
| HY-137905 | Pomalidomide-amido-C5-PEG2-C6-chlorine | 98.75% | Unkown | |
| HY-W096148 | Biotin-C4-amide-C5-NH2 | 95.0% | Unkown | |
| HY-203808 | 5'-Carboxy-modifier C5 | / | Unkown | |
| HY-43941 | Thalidomide-NH-C5-NH2 TFA | 97.02% | Unkown | |
| HY-P1033S1 | [Pyr1]-Apelin-13, Pro(13C5,15N) TFA | 99.85% | Unkown | |
| HY-W006057AS16 | Sodium 3-methyl-2-oxobutanoate-13C5 | 99.00% | Unkown | |
| HY-W654041 | Adenosine monophosphate-13C5 | 96.33% | Unkown | |
| HY-14541S | Olanzapine-d3 | 99.78% | Unkown | |
| HY-14608S4 | L-Glutamic acid-13C5,15N,d5 | 99.9% | Unkown | |
| HY-155672 | JPC0323 | Modulator | 99.5% | Unkown |
| HY-177094 | Izicopan | Antagonist | / | Unkown |
| HY-178275 | Hydrotecan-NH-L-Ala-L-Val-L-Gln(CO-C5-succinimide)-D-glucitol | 98.26% | Unkown | |
| HY-N0390S3 | L-Glutamine-13C5,15N2,d5 | 99.91% | Unkown | |
| HY-R00540A | hsa-miR-30c-5p agomir | 96.15% | Unkown | |
| HY-RI00007A | hsa-let-7c-5p antagomir | 98.65% | Unkown | |
| HY-RI00408 | hsa-miR-200c-5p inhibitor | 97.37% | Unkown | |
| HY-W010184S | 4,6-Dioxoheptanoic acid-13C5 | 99.8% | Unkown | |
| HY-N0322S3 | Cholesterol-13C5 | Agonist | 99.5% | Unkown |
| HY-W010256S3 | D-Xylulose-13C5 | 99.9% | Unkown | |
| HY-W779017 | Thymidine-13C5 | Inhibitor | 99.90% | Unkown |
| HY-129608 | Lenalidomide-acetylene-C5-COOH | 99.26% | Unkown | |
| HY-16637S3 | Folic acid-13C5 | 95.22% | Unkown | |
| HY-130530 | AP-C5 | 99.30% | Unkown | |
| HY-136187A | (S,R,S)-AHPC-C5-NH2 dihydrochloride | 97.8% | Unkown | |
| HY-141902S | Fmoc-Glu(OtBu)-OH-13C5,15N | 96.0% | Unkown | |
| HY-153098A | ARC186 sodium | Inhibitor | 94.13% | Unkown |
| HY-161939 | 7030B-C5 | Inhibitor | 99.78% | Unkown |
| HY-172911 | SHP2-IN-37 | Inhibitor | 96.36% | Unkown |
| HY-R00007 | hsa-let-7c-5p mimic | 91.21% | Unkown | |
| HY-R00007A | hsa-let-7c-5p agomir | 99.93% | Unkown | |
| HY-R00514 | hsa-miR-29c-5p mimic | 96.59% | Unkown | |
| HY-R01569 | hsa-miR-518c-5p mimic | 91.42% | Unkown | |
| HY-W753593 | N4-Acetylcytidine-13C5 | 95.92% | Unkown | |
| HY-113046S | 5-Methyltetrahydrofolic acid-13C5 | 98.09% | Unkown | |
| HY-160901 | CP-289,503 | Inhibitor | 98.21% | Unkown |
| HY-136055 | (S,R,S)-AHPC-C5-COOH | Inhibitor | 98.81% | Unkown |
| HY-W040047S | Pregnanediol 3-glucuronide-13C5 | 95.80% | Unkown | |
| HY-130798 | (S,R,S)-AHPC-amido-C5-acid | 99.58% | Unkown | |
| HY-130849 | (S,R,S)-AHPC-Me-C5-COOH | 96.87% | Unkown | |
| HY-131889 | Thalidomide-O-C5-acid | Inducer | 95.82% | Unkown |
| HY-101343 | RS 39604 | Antagonist | 98.0% | Unkown |
| HY-101755 | Tedatioxetine hydrobromide | Antagonist | 99.83% | Unkown |
| HY-108372 | Boc-C5-O-C5-O-C6-Cl | / | Unkown | |
| HY-10984S3 | Pomalidomide-15N,13C5 | Inducer | 88.33% | Unkown |
| HY-112199 | CP-447697 | Antagonist | 99.70% | Unkown |
| HY-122725 | Lenalidomide-C5-NH2 | 98.45% | Unkown | |
| HY-128848 | Pomalidomide-C2-amido-(C1-O-C5-O-C1)2-COOH | 93.92% | Unkown | |
| HY-131455A | Biotin-C1-PEG3-C3-amido-C5-Gly-Arg-Gly-N3 TFA | 98.0% | Unkown | |
| HY-132856 | Lenalidomide-C5-amido-Boc | 95.10% | Unkown | |
| HY-139336 | Pomalidomide-C5-azide | 97.46% | Unkown | |
| HY-142079 | Br-C1-CONH-C5-CO-Val-Cit-PAB-MMAE | / | Unkown | |
| HY-150918S | 5-Methyl-1H-pyrazole-3-propanoic acid-13C5 | / | Unkown | |
| HY-153098 | ARC186 | Inhibitor | 94.13% | Unkown |
| HY-170820 | XYD049 | Inhibitor | 99.46% | Unkown |
| HY-76082S1 | L-Pyroglutamic acid-13C5 | / | Unkown | |
| HY-P4820A | SYNV-cyclo(CGGYF) TFA | Inhibitor | 97.08% | Unkown |
| HY-R00334 | hsa-miR-181c-5p mimic | 94.04% | Unkown | |
| HY-R00408 | hsa-miR-200c-5p mimic | 95.76% | Unkown | |
| HY-R00540 | hsa-miR-30c-5p mimic | 98.33% | Unkown | |
| HY-RI00334 | hsa-miR-181c-5p inhibitor | 97.20% | Unkown | |
| HY-RI00540 | hsa-miR-30c-5p inhibitor | 96.54% | Unkown | |
| HY-RI00540A | hsa-miR-30c-5p antagomir | 95.34% | Unkown | |
| HY-RI00718 | hsa-miR-34c-5p inhibitor | 98.64% | Unkown | |
| HY-RI00718A | hsa-miR-34c-5p antagomir | 99.11% | Unkown | |
| HY-RS01751 | C5AR2 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W008585 | Benzo-15-crown-5-ether | 99.02% | Unkown | |
| HY-W755003 | Guanosine-13C5 | / | Unkown | |
| HY-W767865 | Cyclic GMP sodium-13C5 | 99.03% | Unkown | |
| HY-W768324 | Ribitol-13C5 | 99.9% | Unkown | |
| HY-W779800 | D-α-Hydroxyglutaric acid-13C5 disodium | 98.87% | Unkown | |
| HY-128729R | DNA2 inhibitor C5 (Standard) | Inhibitor | 97.58% | Unkown |
| HY-135916 | Biotin-C5-amino-C5-amino | ≥98.0% | Unkown | |
| HY-143704S | 5-Aminosalicylic acid-13C6 hydrochloride | 99.53% | Unkown | |
| HY-153785 | NH2-C6-ARC186 sodium | Inhibitor | 92.50% | Unkown |
| HY-159064S | DSPSAPVNVT(Val-13C5,15N)R TFA | 95.00% | Unkown | |
| HY-N0091S | Hypoxanthine-13C5,15N4 | ≥99.0% | Unkown | |
| HY-W028210 | O-Phthalimide-C5-acid | 98.0% | Unkown | |
| HY-W133935S | Diethylenetriaminepentaacetic acid-13C5 pentasodium | / | Unkown | |
| HY-W157299 | 2-(Bromomethyl)-1-fluoro-3-methoxybenzene | / | Unkown | |
| HY-W586819 | C5 Lenalidomide-CH3 | / | Unkown | |
| HY-122725A | Lenalidomide-C5-NH2 TFA | 98.94% | Unkown | |
| HY-141423 | Thalidomide-O-amide-C5-NH2 | Inducer | / | Unkown |
| HY-141423A | Thalidomide-O-amide-C5-NH2 TFA | Inducer | / | Unkown |
| HY-15398S4 | Vitamin D3-13C5 | / | Unkown | |
| HY-175260 | ZN-c5 | Degrader | / | Unkown |
| HY-A0004S | Decitabine-13C5 | / | Unkown | |
| HY-N0437S1 | Progesterone-13C5 | Agonist | / | Unkown |
| HY-W008048S | 2',3'-O-Isopropylideneadenosine-13C5 | / | Unkown | |
| HY-Y1055S4 | Guanine-13C5 | Chemical | 95.0% | Unkown |
| HY-103120 | Org37684 | Antagonist | / | Unkown |
| HY-10446S1 | Pralatrexate-13C5,15N | Inducer | / | Unkown |
| HY-106400 | EGIS 11150 | Antagonist | / | Unkown |
| HY-108487 | N-Acetyl-O-phosphono-Tyr-Glu dipentylamide | Inhibitor | / | Unkown |
| HY-109590S4 | Arachidonic acid-13C5 | 96.6% | Unkown | |
| HY-113062S | 20α-Dihydroprogesterone-13C5 | / | Unkown | |
| HY-113209S2 | 8-Isoprostaglandin F2α-13C5 | / | Unkown | |
| HY-113266S | Valerylcarnitine-d9 | / | Unkown | |
| HY-113420S2 | 11-Dehydro-thromboxane B2-13C5 | / | Unkown | |
| HY-118411S | 5-Ethynyl-2'-deoxyuridine-13C1 | / | Unkown | |
| HY-120498 | RS-64459-193 | Agonist | / | Unkown |
| HY-124117 | LY 278584 | Antagonist | / | Unkown |
| HY-124310 | PDE5-IN-6c | / | Unkown | |
| HY-129085 | 5-Methyl cromolyn disodium | / | Unkown | |
| HY-12956S2 | Dinoprost-13C5 | / | Unkown | |
| HY-130712 | NH2-C2-amido-C2-Boc | / | Unkown | |
| HY-132939 | 2-(2,6-Dioxopiperidin-3-yl)phthalimidine-C5-Br | Chemical | / | Unkown |
| HY-133411A | NH2-O-C5-COOH hydrobromide | / | Unkown | |
| HY-134737 | Boc-NH-PEG1-C5-OH | / | Unkown | |
| HY-134986 | Thalidomide-NH-C5-NH2 | Inducer | / | Unkown |
| HY-136187 | (S,R,S)-AHPC-C5-NH2 | / | Unkown | |
| HY-138098 | Sartorypyrone B | / | Unkown | |
| HY-138848 | Thalidomide-4-O-C5-NH2 | Inducer | / | Unkown |
| HY-138851 | Thalidomide-NH-amido-C5-NH2 | Inducer | / | Unkown |
| HY-138851A | Thalidomide-NH-amido-C5-NH2 hydrochloride | Inducer | / | Unkown |
| HY-139996 | Pomalidomide-C5-Dovitinib | / | Unkown | |
| HY-141062 | N-Methyl-N'-(azido-PEG2-C5)-Cy5 | / | Unkown | |
| HY-141143 | MC(C5)-Val-Cit | / | Unkown | |
| HY-141593 | Modified MMAF-C5-COOH | / | Unkown | |
| HY-14291S2 | Vildagliptin-13C5,15N | Inhibitor | / | Unkown |
| HY-143340 | LEB-03-145 | / | Unkown | |
| HY-144676 | pan-HER-IN-1 | / | Unkown | |
| HY-14520S1 | Tetrahydrofolic acid-13C5 | / | Unkown | |
| HY-14541S2 | Olanzapine-d8 | 99.9% | Unkown | |
| HY-147585 | C5aR-IN-1 | / | Unkown | |
| HY-147586 | C5aR-IN-2 | / | Unkown | |
| HY-147587 | C5aR-IN-3 | / | Unkown | |
| HY-14781S2 | Levomefolic acid-13C5 | / | Unkown | |
| HY-148326 | Glu(OtBu)-Val-Cit-PAB-OH | / | Unkown | |
| HY-148362 | Pomalidomide-C6-O-C5-O-C4-COOH | 98.55% | Unkown | |
| HY-14879S7 | Avibactam-13C5,15N sodium | / | Unkown | |
| HY-149562 | Thalidomide-5-O-C5-NH2 hydrochloride | Inducer | / | Unkown |
| HY-150632 | SARS-CoV-2 nsp13-IN-6 | Inhibitor | / | Unkown |
| HY-150660S | Ercalcidiol-13C5 | / | Unkown | |
| HY-150663S | Calcitriol-13C5 | / | Unkown | |
| HY-153464 | CXCR4-IN-1 | Inhibitor | / | Unkown |
| HY-15401 | WAY 163909 | Agonist | / | Unkown |
| HY-155186 | SARS-CoV-2 3CLpro-IN-19 | Inhibitor | / | Unkown |
| HY-155261 | Pomalidomide-5-C5-NH2 hydrochloride | / | Unkown | |
| HY-155506 | NAMPT degrader-3 | Degrader | / | Unkown |
| HY-157511 | Thalidomide-O-C5-azide | / | Unkown | |
| HY-157933 | SF-C5-TPP | / | Unkown | |
| HY-158627 | JPC0323 Oleate | Modulator | / | Unkown |
| HY-158992S | SP-(Val-13C5,15N)-EKNQ-(Leu-13C6,15N)-TIDFINIVKDPVPHNEYKT TFA | / | Unkown | |
| HY-159570 | XD2-149 | / | Unkown | |
| HY-159571 | Thalidomide-NH-C5-azacyclohexane-N-Boc | / | Unkown | |
| HY-159572 | NH2-C5-Azacyclohexane-N-Boc | / | Unkown | |
| HY-160077 | Pomalidomide-CO-C5-azide | / | Unkown | |
| HY-161132 | Lenalidomide 4'-alkyl-C5-azide | / | Unkown | |
| HY-161793 | (S,R,S)-AHPC-NHCO-C-O-C5-N3 | / | Unkown | |
| HY-162950 | Piperidin-4-amine-C5-O-C1-Thalidomide | / | Unkown | |
| HY-163378 | C5aR1 antagonist 1 | Antagonist | / | Unkown |
| HY-163379 | C5aR1 antagonist 2 | Antagonist | / | Unkown |
| HY-163788 | C5-CONH-C2-N-CH3 | / | Unkown | |
| HY-164084 | DBCO-NHCO-C5-O-phenylethenesulfonyl fluoride | / | Unkown | |
| HY-164829 | Mal-C5-Gly-Gly-Phe-MMAE | Inhibitor | / | Unkown |
| HY-16567S | Asenapine-13C,d3 hydrochloride | Antagonist | / | Unkown |
| HY-16637S2 | (Rac)-Folic acid-13C5,15N | / | Unkown | |
| HY-16637S4 | Folic acid-13C5,15N | / | Unkown | |
| HY-168039 | Boc-NH-Piperidine-C5-OH | / | Unkown | |
| HY-168040 | Thalidomide-O-C5-piperidine-NH-Boc | / | Unkown | |
| HY-169010 | Pomalidomide-CO-C5-Br | / | Unkown | |
| HY-16938S2 | 5'-Methylthioadenosine-13C5 | / | Unkown | |
| HY-172213 | (3S,6R)-NML | Antagonist | / | Unkown |
| HY-172339 | 4-AcO-DALT hydrochloride | Inhibitor | / | Unkown |
| HY-172645 | (S,R,S)-AHPC-Me-amide-C-O-C5-Br | / | Unkown | |
| HY-173010 | Me-(S,R,S)-AHPC-CO-C5-N3 | / | Unkown | |
| HY-173419 | 5-cis-15(R)-Iloprost | / | Unkown | |
| HY-17383S | Levomefolate-13C5 calcium | Chemical | / | Unkown |
| HY-174898 | 5-HT2C agonist-9 | Agonist | / | Unkown |
| HY-175890 | DDB1 ligand-2 | / | Unkown | |
| HY-175981 | Paclitaxel-bromothiophene | / | Unkown | |
| HY-176277S | Fibrinopeptide B, human-(Val-13C5,15N, Arg-13C6,15N4) TFA | / | Unkown | |
| HY-17627S1 | Avacopan-d4 | Inhibitor | / | Unkown |
| HY-176794 | Phenyl-glutarimide 4'-oxyacetic-amide-C5-amide-Boc | / | Unkown | |
| HY-178630S | 2-Hydroxy-5-oxotetrahydrofuran-2-carboxylic acid-13C5 | / | Unkown | |
| HY-180946 | AChE-IN-105 | Inhibitor | / | Unkown |
| HY-181058 | Cyclopamine-COO-2-ethoxy-1,3-benzodioxole-O-C-Triazole-C5-AC | / | Unkown | |
| HY-181312 | CRBN ligand-225-C5-O-C5-NH2 | / | Unkown | |
| HY-18252S1 | Avanafil-13C5,15N,d2 | / | Unkown | |
| HY-183083 | CDK7 ligand 3-CO-C5-COOH | Ligand | / | Unkown |
| HY-183414 | C5aR antagonist-1 | Antagonist | / | Unkown |
| HY-183844 | C5F2-HCB | / | Unkown | |
| HY-184548 | (S,R,S)-AHPC-CO-PEG2-C5-TsO | / | Unkown | |
| HY-184672 | Thalidomide-NH-C2-NH-C5-NH2 | / | Unkown | |
| HY-21994 | Org-12962 hydrochloride | Agonist | / | Unkown |
| HY-32351AS1 | Calcifediol-13C5 monohydrate | / | Unkown | |
| HY-50719S1 | 2-Acetyl-1-pyrroline-13C5 | / | Unkown | |
| HY-A0003S2 | Lenalidomide-13C5,15N | Inducer | / | Unkown |
| HY-B0152S2 | Adenine-13C5,15N5 | Chemical | 95% | Unkown |
| HY-B0434S | Ribavirin-13C5 | Inhibitor | / | Unkown |
| HY-B0456S2 | Riboflavin-13C5 | / | Unkown | |
| HY-B0660S1 | Eicosapentaenoic acid 1,2,3,4,5-13C5 | Activator | / | Unkown |
| HY-B1204S2 | Histamine-13C5, 15N3 | / | Unkown | |
| HY-B1346S | DL-Glutamine-13C5,15N2,d10 | / | Unkown | |
| HY-D1592 | BODIPY TMR C5-maleimide | / | Unkown | |
| HY-D1611 | BODIPY FL-C5 NHS Ester | / | Unkown | |
| HY-D3573 | AF488 C5 Maleimide | / | Unkown | |
| HY-D3576 | AF532 C5 Maleimide | / | Unkown | |
| HY-D3579 | AF568 C5 Maleimide | / | Unkown | |
| HY-D3580 | AF594 C5 Maleimide | / | Unkown | |
| HY-D3582 | AF633 C5 Maleimide | / | Unkown | |
| HY-E71077 | (5R)-Carbapenem-3-carboxylate synthase | / | Unkown | |
| HY-E71200E | 16S rRNA (cytosine1407-C5)-Methyltransferase | / | Unkown | |
| HY-E71200H | 16S rRNA (cytosine967-C5)-Methyltransferase | / | Unkown | |
| HY-E71453J | 23S rRNA (cytosine1962-C5)-Methyltransferase | / | Unkown | |
| HY-E71453U | 23S rRNA (uracil1939-C5)-Methyltransferase | / | Unkown | |
| HY-E71453V | 23S rRNA (uracil747-C5)-Methyltransferase | / | Unkown | |
| HY-E71459B | 25S rRNA (cytosine2278-C5)-Methyltransferase | / | Unkown | |
| HY-E71459C | 25S rRNA (cytosine2870-C5)-Methyltransferase | / | Unkown | |
| HY-I1111S3 | Fmoc-L-Val-OH-13C5 | / | Unkown | |
| HY-N0210S4 | D-Galactose-13C-5 | 99.80% | Unkown | |
| HY-N0379S10 | D-Mannose-13C-5 | 99.83% | Unkown | |
| HY-N0717S2 | L-Valine-13C5,15N,d8 | 99.3% | Unkown | |
| HY-N0717S3 | L-Valine-13C5,15N,d2 | / | Unkown | |
| HY-N12728 | Heteroclitin G | / | Unkown | |
| HY-N13081 | 3-Oxo-cinobufagin | / | Unkown | |
| HY-N19183 | C5-O-Demethyl K41-A | Inhibitor | / | Unkown |
| HY-N3406 | Lansiumarin C | / | Unkown | |
| HY-N7082S | D-Arabinopyranose-13C5 | 99.9% | Unkown | |
| HY-P10274 | CM05 | Inhibitor | / | Unkown |
| HY-P4820 | SYNV-cyclo(CGGYF) | Inhibitor | / | Unkown |
| HY-P4971 | C5a Anaphylatoxin (human) | Modulator | / | Unkown |
| HY-P5081 | Endotrophin (Mus musculus) | Activator | / | Unkown |
| HY-P60514S1 | NQVS-(Leu-13C6,15N)-SCA-(Val-13C5,15N)-K TFA | / | Unkown | |
| HY-P60515S1 | NQVSLWC-(Leu-13C6,15N)-(Val-13C5,15N)-K TFA | / | Unkown | |
| HY-P60516S | ASQDISSA-(Leu-13C6,15N)-(Val-13C5,15N)-WYQQKPGK TFA | / | Unkown | |
| HY-R00334A | hsa-miR-181c-5p agomir | / | Unkown | |
| HY-R00408A | hsa-miR-200c-5p agomir | / | Unkown | |
| HY-R00514A | hsa-miR-29c-5p agomir | / | Unkown | |
| HY-R00718 | hsa-miR-34c-5p mimic | / | Unkown | |
| HY-R00718A | hsa-miR-34c-5p agomir | / | Unkown | |
| HY-R00833 | hsa-miR-374c-5p mimic | / | Unkown | |
| HY-R00833A | hsa-miR-374c-5p agomir | / | Unkown | |
| HY-R00841 | hsa-miR-376c-5p mimic | / | Unkown | |
| HY-R00841A | hsa-miR-376c-5p agomir | / | Unkown | |
| HY-R01113 | hsa-miR-449c-5p mimic | / | Unkown | |
| HY-R01113A | hsa-miR-449c-5p agomir | / | Unkown | |
| HY-R01547 | hsa-miR-513c-5p mimic | / | Unkown | |
| HY-R01547A | hsa-miR-513c-5p agomir | / | Unkown | |
| HY-R01569A | hsa-miR-518c-5p agomir | / | Unkown | |
| HY-R02507 | hsa-miR-892c-5p mimic | / | Unkown | |
| HY-R02507A | hsa-miR-892c-5p agomir | / | Unkown | |
| HY-R02796 | mmu-miR-1970c-5p mimic | / | Unkown | |
| HY-R02796A | mmu-miR-1970c-5p agomir | / | Unkown | |
| HY-R02834 | mmu-miR-216c-5p mimic | / | Unkown | |
| HY-R02834A | mmu-miR-216c-5p agomir | / | Unkown | |
| HY-R02841 | mmu-miR-219c-5p mimic | / | Unkown | |
| HY-R02841A | mmu-miR-219c-5p agomir | / | Unkown | |
| HY-R02883 | mmu-miR-297c-5p mimic | / | Unkown | |
| HY-R02883A | mmu-miR-297c-5p agomir | / | Unkown | |
| HY-R02898 | mmu-miR-302c-5p mimic | / | Unkown | |
| HY-R02898A | mmu-miR-302c-5p agomir | / | Unkown | |
| HY-R03044 | mmu-miR-344c-5p mimic | / | Unkown | |
| HY-R03044A | mmu-miR-344c-5p agomir | / | Unkown | |
| HY-R03105 | mmu-miR-374c-5p mimic | / | Unkown | |
| HY-R03105A | mmu-miR-374c-5p agomir | / | Unkown | |
| HY-R03112 | mmu-miR-376c-5p mimic | / | Unkown | |
| HY-R03112A | mmu-miR-376c-5p agomir | / | Unkown | |
| HY-R03149 | mmu-miR-449c-5p mimic | / | Unkown | |
| HY-R03149A | mmu-miR-449c-5p agomir | / | Unkown | |
| HY-R03164 | mmu-miR-465c-5p mimic | / | Unkown | |
| HY-R03164A | mmu-miR-465c-5p agomir | / | Unkown | |
| HY-R03171 | mmu-miR-466c-5p mimic | / | Unkown | |
| HY-R03171A | mmu-miR-466c-5p agomir | / | Unkown | |
| HY-R03199 | mmu-miR-467c-5p mimic | / | Unkown | |
| HY-R03199A | mmu-miR-467c-5p agomir | / | Unkown | |
| HY-R03461 | mmu-miR-669c-5p mimic | / | Unkown | |
| HY-R03461A | mmu-miR-669c-5p agomir | / | Unkown | |
| HY-R04278 | rno-miR-196c-5p mimic | / | Unkown | |
| HY-R04278A | rno-miR-196c-5p agomir | / | Unkown | |
| HY-R04285 | rno-miR-200c-5p mimic | / | Unkown | |
| HY-R04285A | rno-miR-200c-5p agomir | / | Unkown | |
| HY-R04448 | rno-miR-376c-5p mimic | / | Unkown | |
| HY-R04448A | rno-miR-376c-5p agomir | / | Unkown | |
| HY-R04485 | rno-miR-466c-5p mimic | / | Unkown | |
| HY-R04485A | rno-miR-466c-5p agomir | / | Unkown | |
| HY-RI00007 | hsa-let-7c-5p inhibitor | / | Unkown | |
| HY-RI00334A | hsa-miR-181c-5p antagomir | / | Unkown | |
| HY-RI00408A | hsa-miR-200c-5p antagomir | / | Unkown | |
| HY-RI00514 | hsa-miR-29c-5p inhibitor | / | Unkown | |
| HY-RI00514A | hsa-miR-29c-5p antagomir | / | Unkown | |
| HY-RI00833 | hsa-miR-374c-5p inhibitor | / | Unkown | |
| HY-RI00833A | hsa-miR-374c-5p antagomir | / | Unkown | |
| HY-RI00841 | hsa-miR-376c-5p inhibitor | / | Unkown | |
| HY-RI00841A | hsa-miR-376c-5p antagomir | / | Unkown | |
| HY-RI01113 | hsa-miR-449c-5p inhibitor | / | Unkown | |
| HY-RI01113A | hsa-miR-449c-5p antagomir | / | Unkown | |
| HY-RI01547 | hsa-miR-513c-5p inhibitor | / | Unkown | |
| HY-RI01547A | hsa-miR-513c-5p antagomir | / | Unkown | |
| HY-RI01569 | hsa-miR-518c-5p inhibitor | / | Unkown | |
| HY-RI01569A | hsa-miR-518c-5p antagomir | / | Unkown | |
| HY-RI02507 | hsa-miR-892c-5p inhibitor | / | Unkown | |
| HY-RI02507A | hsa-miR-892c-5p antagomir | / | Unkown | |
| HY-RI02796 | mmu-miR-1970c-5p inhibitor | / | Unkown | |
| HY-RI02796A | mmu-miR-1970c-5p antagomir | / | Unkown | |
| HY-RI02834 | mmu-miR-216c-5p inhibitor | / | Unkown | |
| HY-RI02834A | mmu-miR-216c-5p antagomir | / | Unkown | |
| HY-RI02841 | mmu-miR-219c-5p inhibitor | / | Unkown | |
| HY-RI02841A | mmu-miR-219c-5p antagomir | / | Unkown | |
| HY-RI02883 | mmu-miR-297c-5p inhibitor | / | Unkown | |
| HY-RI02883A | mmu-miR-297c-5p antagomir | / | Unkown | |
| HY-RI02898 | mmu-miR-302c-5p inhibitor | / | Unkown | |
| HY-RI02898A | mmu-miR-302c-5p antagomir | / | Unkown | |
| HY-RI03044 | mmu-miR-344c-5p inhibitor | / | Unkown | |
| HY-RI03044A | mmu-miR-344c-5p antagomir | / | Unkown | |
| HY-RI03105 | mmu-miR-374c-5p inhibitor | / | Unkown | |
| HY-RI03105A | mmu-miR-374c-5p antagomir | / | Unkown | |
| HY-RI03112 | mmu-miR-376c-5p inhibitor | / | Unkown | |
| HY-RI03112A | mmu-miR-376c-5p antagomir | / | Unkown | |
| HY-RI03149 | mmu-miR-449c-5p inhibitor | / | Unkown | |
| HY-RI03149A | mmu-miR-449c-5p antagomir | / | Unkown | |
| HY-RI03164 | mmu-miR-465c-5p inhibitor | / | Unkown | |
| HY-RI03164A | mmu-miR-465c-5p antagomir | / | Unkown | |
| HY-RI03171 | mmu-miR-466c-5p inhibitor | / | Unkown | |
| HY-RI03171A | mmu-miR-466c-5p antagomir | / | Unkown | |
| HY-RI03199 | mmu-miR-467c-5p inhibitor | / | Unkown | |
| HY-RI03199A | mmu-miR-467c-5p antagomir | / | Unkown | |
| HY-RI03461 | mmu-miR-669c-5p inhibitor | / | Unkown | |
| HY-RI03461A | mmu-miR-669c-5p antagomir | / | Unkown | |
| HY-RI04278 | rno-miR-196c-5p inhibitor | / | Unkown | |
| HY-RI04278A | rno-miR-196c-5p antagomir | / | Unkown | |
| HY-RI04285 | rno-miR-200c-5p inhibitor | / | Unkown | |
| HY-RI04285A | rno-miR-200c-5p antagomir | / | Unkown | |
| HY-RI04448 | rno-miR-376c-5p inhibitor | / | Unkown | |
| HY-RI04448A | rno-miR-376c-5p antagomir | / | Unkown | |
| HY-RI04485 | rno-miR-466c-5p inhibitor | / | Unkown | |
| HY-RI04485A | rno-miR-466c-5p antagomir | / | Unkown | |
| HY-RS01749 | C5 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS01750 | C5AR1 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS12597 | SDR16C5 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W000450S | 5-Aminolevulinic acid-13C | / | Unkown | |
| HY-W007035S | H-Val-Ala-OH-13C5,15N TFA | / | Unkown | |
| HY-W008371S1 | Fmoc-Met-OH-13C5,15N | 99.8% | Unkown | |
| HY-W008820S2 | Glutaric acid-d2 | / | Unkown | |
| HY-W009538S1 | 5'-Deoxy-5-fluorocytidine-13C5 | / | Unkown | |
| HY-W010918S3 | Adenosine 5'-diphosphate-13C5 | / | Unkown | |
| HY-W016145S | L-Glutamic acid-13C5 hydrate salt | / | Unkown | |
| HY-W016785S | Glycyl-L-valine-13C5,15N TFA | / | Unkown | |
| HY-W017401S | Benzisothiazolinone-13C6 | Inhibitor | / | Unkown |
| HY-W096134 | Benzyloxy-C5-PEG1 | / | Unkown | |
| HY-W143131S | Diethyl itaconate,98% (stabilized with TBC)-13C5 | / | Unkown | |
| HY-W392941 | Naphtho[1,2-c:5,6-c']difuran-1,3,6,8-tetraone | / | Unkown | |
| HY-W400722 | Sodium 3-methyl-2-oxobutanoate-13C5,d1 | / | Unkown | |
| HY-W746880 | D-Arabinose Phenylhydrazone-13C5 | / | Unkown | |
| HY-W749825 | Pentetic acid-13C5 | / | Unkown | |
| HY-W750576 | 4-Octyl itaconate-13C5 | / | Unkown | |
| HY-W751746 | Dehydro Folic Acid 1,5-Dimethyl Ester-13C5 | / | Unkown | |
| HY-W751764 | Dehydro Folic Acid 1,5-Dimethyl Ester-13C5,15N | / | Unkown | |
| HY-W753201 | 5'-Methylthioadenosine-13C | / | Unkown | |
| HY-W754064 | Cytidine-5'-triphosphate-13C5 | / | Unkown | |
| HY-W756758 | Guanosine-13C5 5'-Monophosphate | / | Unkown | |
| HY-W768207 | Cytidine-1',2',3',4',5'-13C5 | / | Unkown | |
| HY-W768213 | 2'-Deoxyguanosine monohydrate-13C5 | / | Unkown | |
| HY-W768275 | Glucopyranose-13C5 | / | Unkown | |
| HY-W768283 | Guanosine Hydrate-13C5 | / | Unkown | |
| HY-W768302 | D-Lyxose-13C5 | / | Unkown | |
| HY-W768333 | D-Ribofuranose-13C5 | 97.0% | Unkown | |
| HY-W768347 | Xylitol-13C5 | / | Unkown | |
| HY-W769288 | Pemetrexed disodium-13C5 | / | Unkown | |
| HY-W769319 | Inosinic acid-13C5 | / | Unkown | |
| HY-W769319A | Inosinic acid-13C5 TEA | / | Unkown | |
| HY-W777286 | rac-Lenalidomide-13C5 | / | Unkown | |
| HY-W778990 | 2-Deoxyuridine-1,2,3,4,5-13C5 | / | Unkown | |
| HY-W783407S1 | Ac-rG Phosporamidite-13C | / | Unkown | |
| HY-W877850 | Mal-C5-N-bis(PEG2-C2-acid) | 96.25% | Unkown | |
| HY-W998329 | Thalidomide-O-amide-C5-NH2 hydrochloride | Inducer | 95.51% | Unkown |
| HY-Y1055S2 | Guanine-13C5,15N5 | Chemical | / | Unkown |
| HY-Y1166S | N-(9-Fluorenylmethoxycarbonyl)glutamic acid α-tert-butyl ester-13C5,15N | / | Unkown | |
| HY-100805S1 | D-Glutamic acid-13C5,15N | / | Unkown | |
| HY-100805S2 | D-Glutamic acid-13C5 | / | Unkown | |
| HY-106178D | PMX 53 monoacetate | / | Unkown | |
| HY-10984S4 | Pomalidomide-13C5 | Inducer | / | Unkown |
| HY-112675S | 4-Octyl itaconate-13C5-1 | / | Unkown | |
| HY-117872 | Sartorypyrone A | / | Unkown | |
| HY-13599S1 | Cladribine-13C5,15N2 | / | Unkown | |
| HY-144345S | L-γ-Glutamyl-L-cysteinyl-L-lysine-13C5,15N | / | Unkown | |
| HY-147338S1 | 5-Methylcytidine 5′-triphosphate-15N2,13C trisodium | / | Unkown | |
| HY-149691 | O-Phthalimide-C1-S-C5-acid | / | Unkown | |
| HY-149751 | Methylthiomcresol-C5-COOH | / | Unkown | |
| HY-150661S | 3-epi-Calcifediol-13C5 | / | Unkown | |
| HY-15401A | WAY 163909 (hydrochloride) | Agonist | / | Unkown |
| HY-154069 | N-Trityl-N4-benzoyl-morpholino-C-5’-O-phosphoramidite | / | Unkown | |
| HY-15543 | CP-809101 | Agonist | / | Unkown |
| HY-157472 | ACT-1014-6470 | Antagonist | / | Unkown |
| HY-158382 | NH2-C4-PEG4-C5-COOH | / | Unkown | |
| HY-159046S | ASGITFSNSGMHW(Val-13C5,15N)R TFA | / | Unkown | |
| HY-159065S | FIQE(Val-13C5,15N)NTTTR TFA | / | Unkown | |
| HY-160235 | Pomalidomide-C2-amide-C5-azide | / | Unkown | |
| HY-161792 | N3-C5-O-C-Boc | / | Unkown | |
| HY-162948 | (S,R,S)-AHPC-PEG2-C5-N3 | / | Unkown | |
| HY-162949 | Piperidin-4-amine-C5-O-C1 | / | Unkown | |
| HY-16384 | L-156602 | Antagonist | / | Unkown |
| HY-170796 | α-Amylase-IN-11 | Inhibitor | / | Unkown |
| HY-173102S | LQEEIDAVL(Pro-13C5,15N)NK TFA | / | Unkown | |
| HY-173105S | TPEEAHALSA(Pro-13C5,15N)TSR TFA | / | Unkown | |
| HY-173514 | SARS-CoV-2 Mpro-IN-42 | Inhibitor | / | Unkown |
| HY-175260A | ZN-c5 hydrochloride | Degrader | / | Unkown |
| HY-176179S | LFFAADHLV(Val-13C5,15N)CE | / | Unkown | |
| HY-176336 | Thalidomide-C-amide-C5-amine | / | Unkown | |
| HY-176883 | Inositol phosphate amide-C5-NH2 | / | Unkown | |
| HY-177942 | Azide-C5-amide-tri-SA-bis(amide-PBA) | / | Unkown | |
| HY-179849 | BODIPY-butyramide-C5-COO-Lyso PI ammonium | / | Unkown | |
| HY-18206S2 | Lisinopril-13C5,15N | / | Unkown | |
| HY-18252S3 | Avanafil-13C5 | / | Unkown | |
| HY-186237 | Fuc(1→2)-Gal(3→1)(C3-amide-C5-biotin)-GalNAc | / | Unkown | |
| HY-403544 | CbzNH-(C5-O)2-C4-Boc | / | Unkown | |
| HY-B0152S3 | Adenine-13C5 | Chemical | / | Unkown |
| HY-B0368S1 | Captopril-13C5,15N | Inhibitor | / | Unkown |
| HY-B0511S3 | Biotin-13C5 | / | Unkown | |
| HY-B1213S | Trimipramine-d3 maleate | / | Unkown | |
| HY-B2169S2 | Melperone-d4 hydrochloride | 99.84% | Unkown | |
| HY-I1111S2 | Fmoc-L-Val-OH-13C5,15N | 98% | Unkown | |
| HY-P10639A | C5aR2 agonist P32 acetate | Agonist | / | Unkown |
| HY-P3502B | Zilucoplan (PEG2) | Inhibitor | / | Unkown |
| HY-RS18377 | C5ar1 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS22969 | C5 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS24857 | C5ar1 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W010450S5 | Thymine-13C5,15N2 | / | Unkown | |
| HY-W011297S3 | Methyl arachidonate-13C5 | / | Unkown | |
| HY-W013780S1 | Fmoc-Pro-OH-13C5,15N | Inhibitor | / | Unkown |
| HY-W039426 | N-Trityl-N4-benzoyl-morpholino-C-5'-O-phosphoramidite | / | Unkown | |
| HY-W1130286 | NH2-C6-O-C5-O-C4-COOH | / | Unkown | |
| HY-W130878 | 4-Octylphenol | Activator | / | Unkown |
| HY-W251144 | N,N′-Dipentyl-3,4,9,10-perylenedicarboximide | / | Unkown | |
| HY-W338810S | S-(5'-Adenosyl)-L-methionine-13C5 sulfate | / | Unkown | |
| HY-W369104 | Boc-MeN-C5-OH | / | Unkown | |
| HY-W396031 | Boc-NH-C5-NH-Me | / | Unkown | |
| HY-W598206 | (S,R,S)-AHPC-PEG8-NH2 hydrochloride | / | Unkown | |
| HY-W688682 | (S,R,S)-AHPC-C5-NH2 hydrochloride | / | Unkown | |
| HY-W728005 | Covidcil-19 | Inhibitor | / | Unkown |
| HY-W778183 | 3,5,6-Trichloro-2-pyridinol-13C5 | / | Unkown | |
| HY-W778207 | 2'-Deoxyadenosine-13C5 monohydrate | / | Unkown | |
| HY-W779015 | 5-Methyluridine-13C5 | / | Unkown | |
| HY-W779019 | Xylose-13C5 | / | Unkown | |
| HY-W814363 | Octadec-9-enoic acid-13C5 | / | Unkown | |
| HY-W838632 | Antibacterial agent 266 | Inhibitor | 99.46% | Unkown |
| HY-W945790 | Thalidomide-4-O-C5-Br | / | Unkown | |
| HY-W949165 | C5 Lenalidomide-6-fluoro | / | Unkown | |
| HY-W998298 | (S,R,S)-AHPC-C5-PEG3-C3 | / | Unkown | |
| HY-W013081S | Fmoc-Gln(Trt)-OH-13C5,15N2 | / | Unkown |
Bioactive MoleculesInhibitory Antibodies
(10)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P990608 | Alpitatug | 99.13% | Unkown | |
| HY-P992102 | Ascuprubart | Inhibitor | 97.89% | Unkown |
| HY-P992111 | Elfritatug | Inhibitor | 98.98% | Unkown |
| HY-P990998 | Greziprubart | Inhibitor | 97.79% | Unkown |
| HY-P992014 | Anti-Human/Mouse/Monkey CXCR3 Antibody (9C5) | Inhibitor | 99.33% | Unkown |
| HY-P991485 | Anti-CD88/C5AR1 Antibody (G2_anti-C5aR) | Inhibitor | / | Unkown |
| HY-P991788 | Anti-Mouse CCR5 Antibody (C5Mab-2) | Inhibitor | / | Unkown |
| HY-P991811 | Anti-Mouse IFN Alpha Antibody (TIF-3C5) | Inhibitor | / | Unkown |
| HY-P991796 | Anti-Mouse C5aR Antibody (20/70) | Inhibitor | / | Unkown |
| HY-P992215 | Anti-CD85a/LILRB3 Antibody (7C5) | / | Unkown |
Orthologs Information
| Species | Symbol | Source | ID |
|---|---|---|---|
| Homo sapiens | C5 | NCBI | NCBI:727 |
| Macaca fascicularis | C5 | NCBI | NCBI:102125658 |
| Canis lupus familiaris | C5 | NCBI | |
| Mus musculus | C5 | NCBI | |
| Susscrofa domestica | C5 | NCBI | |
| Leporidae | C5 | NCBI | |
| Rattus norvegicus | C5 | NCBI | NCBI:362119 |
| Macaca mulatta | C5 | NCBI | NCBI:700467 |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service